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Obesity leads to ovarian dysfunction and the establishment of local leptin resistance.
The aim of our study was to characterize the levels of NOD-like receptor protein 3
(NLRP3) inflammasome activation in ovaries and liver of mice during obesity progression.
Furthermore, we tested the putative role of leptin on NLRP3 regulation in those organs.
C57BL/6J female mice were treated with equine chorionic gonadotropin (eCG) or human
chorionic gonadotropin (hCG) for estrous cycle synchronization and ovary collection.
In diet-induced obesity (DIO) protocol, mice were fed chow diet (CD) or high-fat diet
(HFD) for 4 or 16 weeks, whereas in the hyperleptinemic model (LEPT), mice were
injected with leptin for 16 days (16 L) or saline (16 C). Finally, the genetic obese leptin-
deficient ob/ob (+/? and −/−) mice were fed CD for 4 week. Either ovaries and liver
were collected, as well as cumulus cells (CCs) after superovulation from DIO and LEPT.
The estrus cycle synchronization protocol showed increased protein levels of NLRP3
and interleukin (IL)-18 in diestrus, with this stage used for further sample collections.
In DIO, protein expression of NLRP3 inflammasome components was increased in
4 week HFD, but decreased in 16 week HFD. Moreover, NLRP3 and IL-1β were
upregulated in 16 L and downregulated in ob/ob. Transcriptome analysis of CC showed
common genes between LEPT and 4 week HFD modulating NLRP3 inflammasome.
Liver analysis showed NLRP3 protein upregulation after 16 week HFD in DIO, but
also its downregulation in ob/ob−/−. We showed the link between leptin signaling and
NLRP3 inflammasome activation in the ovary throughout obesity progression in mice,
elucidating the molecular mechanisms underpinning ovarian failure in maternal obesity.
Keywords: ovary, inflammation, obesity, NLRP3 inflammasome, leptin
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INTRODUCTION
Obesity leads to chronic systemic inflammation, a process
mostly promoted by the continuous expansion of adipose tissue
(Hotamisligil and Erbay, 2008; Odegaard and Chawla, 2008).
Importantly, obesity is strongly linked to reproductive failure and
infertility in women (Chu et al., 2007). The ovaries of mice fed a
high-fat diet (HFD) show increased apoptosis and fewer mature
oocytes (Jungheim et al., 2010). Furthermore, we have recently
identified a striking link between maternal body weight in diet-
induced obese (DIO) mice and global gene expression in cumulus
cells (Wołodko et al., 2020). Other readouts of ovarian failure
during maternal obesity comprise lipotoxicity, endoplasmic
reticulum (ER) stress, and mitochondrial dysfunction (Wu
et al., 2010). Ultimately, impaired ovarian function in obese
mothers determines poor oocyte quality and abnormal embryo
development (Minge et al., 2008), as obesity in women has
been largely associated with failure in embryo implantation
and abortion (Chu et al., 2007; Robker, 2008; Penzias, 2012).
Thus, ovarian failure and decreased oocyte quality contribute to
infertility in obese mothers.
Maternal obesity has other implications beyond infertility.
The impact of maternal of obesity in offspring health represents
a greater economic and social burden. Fetal congenital
abnormalities were reported in obese mothers (Samuelsson
et al., 2008). Furthermore, reports suggested also increased
predisposition to cardiovascular disease (Loche et al., 2018) and
type 2 diabetes (Blüher, 2019) in the offspring born from obesity
mothers. Therefore, maternal obesity presents major long-term
implications for offspring development and health.
The white adipose tissue (WAT) is a major endocrine organ
and, alongside skeletal muscle and the liver, regulates whole
body insulin sensitivity and glucose homeostasis (Czech, 2020).
Maternal obesity is associated with systemic hormonal imbalance,
largely characterized by excessive expansion of white adipose
tissue and increased circulating levels of insulin, cholesterol,
and leptin (Wołodko et al., 2020), among others. We have
recently demonstrated that the establishment of leptin resistance
in the ovaries of mice treated with HFD (Wołodko et al.,
2020) was mostly mediated by suppressor of cytokine signaling
3 (SOCS3). Hence, early increase in ovarian leptin signaling
and overexpression of SOCS3 protein after 4 weeks of DIO,
was followed by failure in leptin receptor (ObR) b activation
and leptin resistance after 16 week DIO (Wołodko et al.,
2020). Furthermore, leptin is a well-known regulator of ovarian
function (Karlsson et al., 1997; Ryan et al., 2002), with the
aforementioned changes in leptin signaling in the ovaries of
obese mothers potentially affecting major functional events
like follicular pool activation, oocyte maturation, and ovulation
(Wołodko et al., 2021).
The inflammasome is a large intracellular protein complex
that contains a cytosolic pattern recognition receptor.
Among NOD-like receptors (NLR), the NLR protein 3
(NLRP3) inflammasome has been best characterized as
a complex of proteins responsible for controlling the
activity of two proinflammatory cytokines interleukin
(IL)-1β and IL-18 (Martinon et al., 2002; Davis et al., 2011;
De Nardo and Latz, 2011). Activation of the pattern recognition
receptor NLRP3 can be accomplished through two major
signals: (i) priming signal, induced by the Toll-like receptor
(TLR)/nuclear factor (NF)-κB pathway, and (ii) pathogen-
associated molecular patterns (PAMPs) and damage-associated
molecular patterns (DAMPs) leading to assembly of
inflammasome (Martinon et al., 2002; Lamkanfi and Dixit,
2014). Both mechanisms lead to the recruitment of the adapter
apoptosis-associated speck-like protein containing a C-terminal
caspase recruitment domain (ASC), resulting in the activation of
pro-caspase-1 (CASP1) and cleavage into the active form (Davis
et al., 2011). The formation and activation of the inflammasome
is possible through ASC, which links NLRP3 to CASP1 by means
of its pyrin and caspase recruitment domain motifs (Martinon
et al., 2006). Finally, activated CASP1 is known to process the
maturation of IL-1β and IL-18 into active cytokines (Lamkanfi,
2011). Importantly, obesity and insulin resistance (IR) have
been associated with inflammation and subsequent activation
of NLRP3 inflammasome (Traba and Sack, 2017). The onset
of inflammasome activation was also shown to be mediated by
factors like glucose, ceramide, uric acid, or lipopolysaccharide
(LPS) (Stienstra et al., 2012; Traba and Sack, 2017). Furthermore,
secondary signals like extracellular ATP inducing K+ efflux,
DAMPs/PAMPS leading to reactive oxygen species (ROS)
production can also activate NLRP3 inflammasome (Shao
et al., 2015; Tõzsér and Benkõ, 2016). Saturated free fatty acids
(FFAs) were equally linked to inflammasome activation through
both signals (Wen et al., 2011), as increased levels of FFAs
are a general feature of obesity, IR, or type-2 diabetes (Boden,
2002; Krebs and Roden, 2005). More recently, a link has been
also established between NLRP3 inflammasome activation
and levels of leptin signaling in various cellular contexts
(Fu et al., 2017), substantiating leptin proinflammatory role
(Cauble et al., 2018).
A recent report has shown the presence of NLRP3
inflammasome components at ovarian level during follicular
development in mice, suggesting its involvement in ovulation
(Z. Zhang et al., 2019). Most importantly, NLRP3 was also
suggested to be involved in the pathophysiology of polycystic
ovary syndrome (PCOS) (Rostamtabar et al., 2020). Therefore,
we presently hypothesize that the regulation of NLRP3 in
the ovary of obese mice is mediated by local leptin signaling.
We first confirmed that NLRP3 inflammasome expression
profile changed in the ovaries of cyclic mice. Subsequently,
we revealed that NLRP3 inflammasome components were
differently expressed in the ovaries of 4- and 16- week DIO
mice. Furthermore, using a mouse model of pharmacological
hyperleptinemia (LEPT) and a genetic obese mouse, which
lacks leptin (ob/ob), we demonstrated the association between
levels of leptin signaling and NLRP3 inflammasome activation
in the ovary of obese mice. Moreover, we re-analyzed the
transcriptome of cumulus cells (CCs) from DIO and LEPT
models and concluded that leptin treatment upregulated genes
associated with NLRP3 inflammasome in CCs. Finally, we
studied the NLRP3 inflammasome component expression
in the liver of DIO, LEPT, and ob/ob mice. We observed a
consistent downregulation in NLRP3 inflammasome activity in
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ob/ob, which are obese and lack leptin, denoting once more the
important link between NLRP3 and leptin activity.
MATERIALS AND METHODS
Animals and Protocols
Breeding pairs were purchased from Jackson Laboratories (Bar
Harbor, ME, United States). Female C57BL/6J (B6) mice (8-
week old) and B6.Cg-Lepob/J (ob/ob) were housed in the Animal
Facility of Institute of Animal Reproduction and Food Research,
Polish Academy of Sciences in Olsztyn. Mice were housed with
free access to food and water for the duration of the study
(humidity 50 ± 10%; 23◦C; 12L:12D cycle). All procedures were
approved by the Local Animal Care and Use Committee for
the University of Warmia and Mazury in Olsztyn. Guidelines
for animal experiments followed EU Directive 2010/63/EU.
Throughout the experiments, mice were monitored for any sings
of welfare or disease. At 8 week of age, mice were subjected to
various protocols.
For hormonal treatment protocol, the estrous cycle was
monitored after vaginal cytology analysis. Cells were collected on
a glass slide and stained with Diff Quik R© kit (Medion Diagnostics
AG, Switzerland, DQ-ST). Estrus (E) was characterized by
cornified epithelium cells, metestrus by both cornified cells
and leukocytes, diestrus (D) by predominant leukocytes, and
proestrus by nucleated cells, as previously described (Kyrönlahti
et al., 2011). Subsequently, mice received either eCG or hCG,
as previously described (Hasegawa et al., 2016). One group of
female B6 mice (seven to eight mice/group) was injected in E
with equine chorionic gonadotropin (eCG, G4877; 5 IU, Sigma
Aldrich) followed by human chorionic gonadotropin (hCG,
Chorulon, 5 IU, MSD Animal Health) 48 h after, and tissues
were collected 18–20 h later in E. In the second group (seven to
eight mice/group), animals were injected with hCG, and tissues
were collected 16–18 h later in D. In the DIO model, mice (8–
10/group) were placed on standard chow diet (CD, #5053, Picolab
Rodent diet 20 with 13% of calories) or HFD (59% of calories,
AIN-76A with 33% hydrogenated coconut oil; LabDiet) for 4 or
16 week. In the hyperleptinemic model (8–10 mice/group), high
circulating levels of leptin were obtained through intraperitoneal
administrations of leptin twice (100 µg/day injected at 09:00 and
21:00), while the control group received saline (Recombinant
Mouse Leptin, GFM26, Cell Guidance Systems). Regarding
the ob/ob model, mice (8–10 mice/ group) were kept on CD
until 12 week of age.
Immunohistochemistry and
Immunofluorescence
Both immunohistochemistry (IHC) and immunofluorescence
(IF) followed the protocols previously described (Wołodko et al.,
2020). Briefly, mouse ovaries were collected during the D stage,
fixed in 4% paraformaldehyde, and stored at 4◦C. On the
following day, the tissues were dehydrated in ethanol. Paraffin
embedded tissues were then cut in 5-µm sections and mounted
on a glass slide. After deparaffinization in xylene, samples were
rehydrated in increasing ethanol concentrations. For antigen
retrieval, sections were boiled in citrate buffer (10 mM, pH = 6).
Next, sections were incubated with BSA (A2153; Sigma Aldrich)
for 1 h at room temperature (RT), followed by incubation with
rabbit polyclonal antibody against NLRP3 (1:200, ab214185;
Abcam) overnight at 4◦C. In order to test the specificity of
the primary antibody, sections were also incubated with rabbit
polyclonal anti-immunoglobulin G (IgG, ab37415; Abcam) or
without primary antibody (negative controls). On the following
day, sections were washed and incubated for 1 h at RT with
peroxidase-conjugated goat anti-rabbit IgG polyclonal antibody
(1:100, 410972; Dako). Finally, slides were incubated in 3,3-
diaminobenzidine (DAB) for 15 s before visualization. The
sections were then counterstained for 2 min using hematoxylin
(MHS16; Sigma Aldrich). Stained sections were dehydrated and
mounted under glass coverslips.
Concerning the immunofluorescence protocol, after
deparaffinization in xylene, samples were in increasing ethanol
concentrations. Sections were then permeabilized in 0.3% Triton
X-100 (T8787; Sigma Aldrich) two times for 5 min at RT.
Antigen retrieval was done after heating the sections in citrate
buffer (10 mM, pH = 6). Blocking was done with BSA (A2153;
Sigma Aldrich) with 0.3 M glycine (G8898; Sigma Aldrich)
in phosphatase-buffered saline (PBS)–0.1% Tween 20 (P7949;
Sigma Aldrich) (PBST) solution for 2 h, at RT. In order to
minimize the autofluorescence, tissues were treated with 0.3%
Sudan Black (199664; Sigma Aldrich) (in 70% ethanol) for
10 min at RT. Subsequently, sections were washed eight times
for 5 min in PBST (0.1% Tween20). The sections were then
incubated with rabbit polyclonal antibody against NLRP3 (1:100,
NBP2-12446; Novus Biologicals) overnight at 4◦C. The negative
controls were after incubating the slides with rabbit polyclonal
anti-immunoglobulin G (IgG, ab37415; Abcam) or without
primary antibody (negative controls). On the following day, the
sections were washed six times for 5 min in PBST at RT, followed
by incubation with the secondary antibody cyanine 3 (Cy3)-
AffiniPure donkey polyclonal anti-rabbit IgG (H+L) (1:400,
711-165-152; Jackson ImmunoResearch) for 2 h at RT. The
sections were washed six times for 5 min in PBST at RT. In order
to visualize the nucleus, DAPI (dilution 1:100 with PBS, D9542-
10MG; Sigma Aldrich) was added for 30 min at RT. Finally, the
slides were covered with Vectashield medium (H-1000; Vector
Laboratories) and stored at −20◦C. Images were captured using
Zeiss Axio Observer System (Carl Zeiss, Germany) with× 20/0.4
NA, and confocal microscope (Zeiss LSM 800) with × 40/1.2
or × 63/1.4 NA oil immersion objectives. For examination
of the slides, an Axio Observer Systems Z1 microscope (Carl
Zeiss Microscopy GmbH, Germany) and the Zeiss ZEN 2.5 lite
Microscope Software (Carl Zeiss, Germany) were used.
Protein Extraction and Western Blotting
Analysis
Protein expression in mouse ovary and liver was assessed by
Western blotting. Ovaries and livers were homogenized with
RIPA buffer (R0278; Sigma Aldrich) after adding protease
inhibitors (phenylmethylsulfonyl fluoride, PMSF and Protease
Inhibitor Cocktail, P8340; Sigma-Aldrich) and phosphatase
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inhibitors (Pierce Phosphatase Inhibitor Mini Tablets 88667;
Thermo Fisher Scientific) and incubating on ice for 1 h. After
centrifugation (20,000 × g, 15 min, 4◦C), the supernatants
were collected, and protein concentration was determined
with the Smith et al. (1985) copper/bicinchoninic assay
[Copper (II) Sulfate, C2284; Sigma and Bicinchoninic Acid
Solution, B9643; Sigma Aldrich]. Samples were run (40 µg
of protein) on 10–18% polyacrylamide gels. After transfer,
the membranes were blocked in PBS solution containing
3% powdered milk for 1 h. Immunoblotting was performed
using the primary antibodies NLRP3 (AG-20B-0014-C100;
Adipogen), CASP1 (ab108362; Abcam), IL-18 (ab71495; Abcam),
β-actin (A2228; Sigma Aldrich) and glyceraldehyde 3-phosphate
dehydrogenase (GAPDH, ab9485; Abcam) on nitrocellulose
(10600009; GE Healthcare Life Science) or polyvinylidene
fluoride (PVDF) membrane (IPVH00010; Merck Millipore).
Primary antibodies were incubated overnight at 4◦C. The
following day, proteins were detected by incubating the
membranes with polyclonal anti-mouse horseradish peroxidase
(HRP)-conjugated secondary (1:10,000, 31430; Thermo Fisher
Scientific), polyclonal anti-rabbit HRP-conjugated secondary
(1:20,000, 31460; Thermo Fisher Scientific), polyclonal anti-
mouse alkaline phosphatase-conjugated secondary (1:10,000,
31321; Thermo Fisher Scientific), and polyclonal anti-rabbit
alkaline phosphatase-conjugated secondary (1:10,000, A3687;
Sigma Aldrich) antibodies, for 1.5 h in the chemiluminescence
method or 2.5 h in the colorimetric method at RT. All antibody
specifications are summarized in Table 1. Immunocomplexes
were visualized subsequently using chemiluminescence detection
reagent (SuperSignal West Femto kit, 34095; Thermo Fisher
Scientific) or chromogenic substrate NBT/BCIP diluted 1:50
(11681451001; Roche) in alkaline phosphate buffer. Band density
for each of the target protein was normalized against β-actin
for NLRP3 and IL-18, while GAPDH was used for CASP1 as
a reference protein. Finally, bands were quantified using the
TABLE 1 | Specification of antibodies used for Western blotting.
Antibody name and
specificity





























Goat anti-mouse IgG (H+L)
secondary antibody, HRP
Thermo Fisher Scientific Cat#
31430, RRID:AB_228307
1:1,000
Goat anti-rabbit IgG (H+L)
secondary antibody, HRP
Thermo Fisher Scientific Cat#
31460, RRID:AB_228341
1:20,000
Goat anti-mouse IgG (H+L)
secondary antibody, AP
Thermo Fisher Scientific Cat#
31321, RRID:AB_10959407
1:1.000
ChemiDoc or VersaDoc MP 4000 imaging system (Bio-Rad).
Quantitative measurements of blot intensity were performed
using ImageLab software.
Total RNA Isolation and cDNA Synthesis
Total RNA was extracted from whole ovary and 10 mg of
liver, using TRI reagent (T9424; Sigma Aldrich) following the
instructions of the manufacturer. RNA samples were stored
at −80◦C. Concentration and quality of RNA was determined
spectrophotometrically, and the ratio of absorbance at 260 and
280 (A260/280) was analyzed confirming good RNA quality.
Subsequently, 2 µg of RNA was reverse transcribed into cDNA
using Maxima First Strand cDNA Synthesis Kit for RT-qPCR
(K1642; Thermo Fisher Scientific) (Galvão et al., 2012).
Real-Time PCR
Real-time PCR assays were performed in a 7900 Real-time System
(Applied Biosystems), using a default thermocycler program for
all genes: a 10-min preincubation at 95◦C was followed by 45
cycles of 15 s at 95◦C and 1 min at 60◦C. A further dissociation
step (15 s at 95◦C, 15 s at 60◦C, and 15 s at 95◦C) ensured the
presence of a single product. Ribosomal protein L37 (Rpl37) was
chosen as a housekeeping gene and quantified in each real-time
assay together with the target gene. Based on gene sequences
in GenBank (National Center for Biotechnology Information),
the primers for Nlrp3, Casp1, Il-1β, Il-18, Asc, Il-10, and Tnf,
which sequences are presented in Table 2, were designed using
Primer Express 3.0 software (Applied Biosystems). All reactions
were carried out in duplicates in 384-well plate (4309849; Applied
Biosystems) in 12 µl of total solution volume (Galvão et al., 2014).
The data were analyzed using the real-time PCR Miner algorithm
(Zhao and Fernald, 2005).
Enzyme-Linked Immunosorbent Assay
Immunoassay
The concentrations of IL-1β in tissue extracts of ovaries and
livers were determined using an IL-1 beta Pro-form Mouse
Uncoated ELISA kit (88-8014-22; Thermo Fisher Scientific)
following the instructions of the manufacturer. The standard
curve concentrations ranged from 25 to 3,000 ng/m, and
interassay coefficient variation (CV) was 7.27%.
RNA-Seq Data From Cumulus Cells
We used RNA-seq data from CCs previously produced by
Wołodko et al. (2020). The dataset is publicly available under
the GEO accession number GSE1803001. Library generation was
previously described (Wołodko et al., 2020). Briefly, we collected
approximately 50 CCs per animal, after superovulation, and
RNA-seq libraries were generated using a Smart-seq2 oligo-
dT method. Read counts were normalized by size factor and
log-2 transformed. Partial correlations were used to determine
coexpressing genes (cor > 0.9) using the corpcor package
(Schäfer and Strimmer, 2005). Network statistics were calculated
using the igraph package (Csárdi and Nepusz, 2006). Network
visualization was done with Cytoscape (Shannon et al., 2003).
1https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE180300
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TABLE 2 | Specific primers used for quantitative real-time PCR.
Gene name Gene symbol GenBank accession No. Sequences 5′–3′ Length (base pairs)
NLR family pyrin domain-containing 3 Nlrp3 NM_145827.4 F: TGGATGGGTTTGCTGGGATA
R: TGCTTGGATGCTCCTTGACC
190
Caspase 1 Casp1 NM_009807.2 F: CATGCCGTGGAGAGAAACAA
R: GGTGTTGAAGAGCAGAAAGCAA
151
Interleukin-1β IL-1β NM_008361.4 F: TTGACGGACCCCAAAAGATG
R: GCTTCTCCACAGCCACAATGA
144





Asc NM_023258.4 F: GCTTAGAGACATGGGCTTACAGGA
R: CCAGCACTCCGTCCACTTCT
179
Interleukin-10 Il-10 NM_010548.2 F: CCTGGGTGAGAAGCTGAAGAC
R: CTGCTCCACTGCCTTGCTCT
91





Rpl37 NM_026069.3 F: CTGGTCGGATGAGGCACCTA
R: AAGAACTGGATGCTGCGACA
108
Statistical Analysis and Data
Presentation
Statistical analyses were performed using the GraphPad Prism
Software (Version 9.01, GraphPad Software, Inc.; La Jolla, CA,
United States). Sample normal distribution was determined using
the D’Agostino–Pearson omnibus test. Mann–Whitney test,
simple t-test, or multiple unpaired t-test were used to analyze the
data, and statistical significance was calculated with Bonferroni–
Sidak corrections for multiple comparison, depending on the
experiment (details in figure legend). Results were presented as
means with standard deviation. Differences between means for
all tests were considered statistically significant if p < 0.05.
RESULTS
NOD-Like Receptor Protein 3
Inflammasome Components Expression
Change in the Ovary of Cyclic Mice
We first sought to characterize the expression of NLRP3-induced
inflammasome components in the ovaries of mice throughout
the estrous cycle. Fifteen female 8-week-old C57BL/6 (B6) mice
were treated with hormones in order to synchronize the estrous
cycle (Figure 1A). Ovaries were collected in the E and D stage
and further processed for mRNA or protein expression analysis,
respectively. Real-time PCR analysis (n = 6–7/group) revealed
increased levels of Casp1, Il-1β, and Il-18 mRNA in the D stage
(Figure 1B, p < 0.05). Moreover, Western blotting (n = 7–
8/group) revealed increased NLRP3 protein expression in D
(Figure 1C, p < 0.05), as well as the pro-peptide (p24) and mature
form (p18) of IL-18 (Figures 1F,G; p < 0.01). Regarding CASP1,
the long form (p45) was decreased in D (Figure 1D; p < 0.05),
but no significant changes were observed for the active CASP1
(p20) (Figure 1E). These results suggest the activation of NLRP3
inflammasome in the D stage, through upregulation of NLRP3
and its downstream mediator IL-18. Next, we characterized the
cellular distribution of NLRP3 protein in the ovaries collected
from mice in D, using IHC and IF (n = 2–3/group). We
confirmed that NLRP3 protein was visible in ovarian follicles,
corpora lutea, and interstitial space (Figure 1I). On the other
hand, a closer observation of IHC sections revealed staining in
granulosa cells (GC) and theca cells (TC), as well as in oocytes,
in all developmental follicular stages (Figures 1K–M). Negative
controls stained exclusively with secondary antibodies did not
reveal any brown staining (Figures 1H,J). The specificity of our
IHC staining was corroborated by IF, in which a clear yellow
staining was observed in GC, TC, and oocytes (Figures 1O–Q).
Negative control stained with rabbit immunoglobulin type G
(IgG) confirmed no staining (Figure 1N). Our results not only
confirmed the presence of NLRP3 protein in GC, TC, and oocytes
by IHC and IF, but also confirmed the upregulation of NLRP3
in the ovaries of eCG-treated mice. Therefore, in subsequent
experiments, collections were consistently performed in D.
Activation of NOD-Like Receptor Protein
3-Induced Inflammasome in the Ovary of
Diet-Induced Obesity Mice
In the following experiment, we tested the effects of short-
(4 week) vs. long-term (16 week) HFD treatment on NLRP3-
induced inflammasome activation in the ovary of mice
(Figure 2A). Throughout the mouse DIO protocol, the average
body weight (BW) was recorded every 4 week (Table 3).
After collection, ovaries were processed for mRNA and protein
expression analysis. Real-time PCR analysis (n = 6–8/group)
revealed increased mRNA of Nlrp3 after 4-week HFD (Figure 2B,
p = 0.06), whereas Il-1β levels were increased after both 4 and
16 week of HFD (Figure 2B, p < 0.05). Regarding Western
blotting analysis (n = 7–8/group), we found that the expression
of NLRP3, CASP1 p45, and pro IL-18 p24 were increased
in the 4-week HFD group, compared with the control group
(Figures 2C,D,F, p < 0.05, respectively). The opposite pattern
was seen after 16-week HFD, with the downregulation of NLRP3
expression, the mature form of CASP1 p20 and both forms of IL-
18 (p24 and p18) (Figures 2C,E–G, p < 0.05). Finally, we also
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FIGURE 1 | Characterization of NOD-like receptor protein 3 (NLRP3) expression in the ovary of cyclic mice. (A) Experimental design: estrous cycle synchronization
with equine chorionic gonadotropin (eCG) and human chorionic gonadotropin (hCG) as previously described (Hasegawa et al., 2016). Ovaries were collected from
animals in the estrus (E) or diestrus (D) stage of the cycle. Quantification of mRNA levels of (B) Nlrp3, caspase-1 (Casp1), interleukin-1β (Il-1β), and interleukin-18
(Il-18) by real-time PCR. Abundance of (C) NLRP3, (D) pro CASP1 p45, (E) CASP1 p20, (F) pro IL-18 p24, and (G) IL-18 p18 protein during (E,D) measured by
Western blotting analysis. Data were normalized to ribosomal protein L37 (Rpl37) mRNA expression and β-actin of or glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) protein expression. Bars represent mean ± SEM. Statistical analysis between groups was carried out using Mann–Whitney. Number of samples: n = 6–7
for real-time PCR analysis and n = 7–8 immunoblots. Asterisks indicate significant differences (∗p < 0.05; ∗∗p < 0.01). Representative immunohistochemistry (IHC)
staining (n = 2–3) of NLRP3 protein during follicular development in the mouse ovary. Positive staining in brown, counterstaining with hematoxylin. (H,J) Negative
control incubated with secondary antibody. Localization of NLRP3 in (I) whole ovary of 16 weeks (wk) mice fed chow diet (CD), (K) primary follicles of 16- week CD
mice, (L) secondary follicles of 16- week high-fat diet (HFD) mice, and (M) preantral follicles of 16- week CD mice. Staining was detected in granulosa (GC) and
theca cells (TC). Faint staining was observed in the oocytes of all stages of folliculogenesis. Arrows denote GC, arrowheads denote TC, and asterisks denote
oocytes. The IHC staining was confirmed by immunofluorescent localization of NLRP3. Positive staining in orange, nuclear counterstaining with DAPI in blue.
(N) Negative control 16- week CD stained with polyclonal rabbit IgG. NLRP3 localized in (O) whole ovary, (P) secondary follicles of 16- week CD mice, (Q) preantral
follicles of 16- week HFD mice. Inserts on the top left corners represent magnifications of GC. Scale bars represent 20 or 100 µm. AU, arbitrary units.
Frontiers in Cell and Developmental Biology | www.frontiersin.org 6 November 2021 | Volume 9 | Article 738731
fcell-09-738731 October 28, 2021 Time: 16:28 # 7
Adamowski et al. Ovarian Leptin Regulates NLRP3-Inflammasome in Obesity
FIGURE 2 | Diet-induced obesity (DIO) changes NLRP3 expression in the ovary. (A) Experimental design: Mice were fed either chow diet (CD) or high-fat diet (HFD)
for 4 or 16 weeks (wk) and ovaries were collected during the diestrus stage. Quantification of (B) Nlrp3, Casp1, Il-1β, and Il-18 mRNA by real-time PCR. Abundance
of (C) NLRP3, (D) pro CASP1 p45, (E) CASP1 p20, (F) pro IL-18 p24, (G) IL-18 p18 protein measured by Western blotting and (H) IL-1β protein measured by
enzyme-linked immunosorbent assay (ELISA) in ovarian extracts collected from DIO mice. mRNA level was normalized with ribosomal protein L37 (Rpl37) value and
protein expression with β-actin or glyceraldehyde 3-phosphate dehydrogenase (GAPDH) level. Bars represent mean ± SEM. Differences between control and
treatment groups analyzed with Mann–Whitney in real-time PCR and ELISA and multiple t-test for Western blotting. Number of samples: n = 6–8 for real-time PCR,
n = 7–8 for immunoblots, and n = 4–6 for ELISA. Asterisks indicate significant differences (*p < 0.05; **p < 0.01; +p = 0.06; +p = 0.07 or +p = 0.082—all values
indicated). AU, arbitrary units.
confirmed that IL-1β protein level was upregulated in 16-week
HFD by enzyme-linked immunosorbent assay (ELISA) (n = 4–6)
(Figure 2H, p = 0.082). We presently showed that despite the
upregulation of NLRP3, the pro-proteins IL-18 (p18, p24) and
CASP1 (p45) after 4-week HFD treatment, the expression profile
of NLRP3, CASP1 (p20), and both forms of IL-18 (p18, p24) were
consistently downregulated after a 16-week HFD treatment.
Leptin Signaling in the Ovary Drives
Activation of NOD-Like Receptor Protein
3 Inflammasome During Obesity
Progression
After temporally characterizing the expression profile of NLRP3-
induced inflammasome components in the ovary of DIO mice,
we further interrogated whether the activation of NLRP3
inflammasome was regulated by leptin signaling. Therefore,
we analyzed the levels of NLRP3 inflammasome components
in the ovaries of a previously validated mouse model of
pharmacological hyperleptinemia, which presented increased
systemic levels of leptin and increased leptin signaling in the
ovary without obesity (Wołodko et al., 2020), and a genetically
obese mouse ob/ob characterized by extreme obesity and lack
of circulating leptin. In the pharmacological hyperleptinemic
model (n = 8–10/group), B6 female mice were treated with
leptin intraperitoneally 16 days (16 L), whereas controls were
administered saline (16 C) (Wołodko et al., 2020). Moreover,
in the ob/ob model (n = 8–10/group), control females (+/?)
and homozygous mutant females (−/−) were kept on CD for
4 week (Figure 3A). Body weights of the mice were registered
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TABLE 3 | Body weight measurement of three mouse models.
0 week 4 week 8 week 12 week 16 week
CD 17.0 ( ± 0.6) g 19.7 ( ± 1.0) g 20.0 ( ± 0.9) g 20.9 ( ± 1.0) g 22.6 ( ± 2.5) g
HFD 19.4 ( ± 0.8) g 24.8 ( ± 2.5) g**** 29.1 ( ± 3.6) g**** 33.1 ( ± 4.3) g**** 37.6 ( ± 3.7) g****
0 day 3 days 9 days 12 days 16 days
C 21.7 ( ± 1.7) g 22.8 ( ± 2.0) g 22.1 ( ± 2.1) g 21.5 ( ± 1.6) g 21.9 ( ± 1.9) g
L 21.8 ( ± 1.9) g 20.5 ( ± 1.9) g 19.0 ( ± 1.4) g** 18.5 ( ± 1.2) g*** 19.4 ( ± 1.7) g
8 week 9 week 10 week 11 week 12 week
ob/ob +/? 20.9 ( ± 1.6) g 21.5 ( ± 1.6) g 22.2 ( ± 1.6) g 22.8 ( ± 2.1) g 22.7 ( ± 2.1) g
ob/ob –/– 39.8 ( ± 5.4) g**** 43.1 ( ± 5.0) g**** 45.0 ( ± 4.7) g**** 47.4 ( ± 5.7)**** 48.8 ( ± 4.0) g****
DIO, Diet-induced obese; CD, mice were fed chow diet; HFD, high-fat diet (ii) pharmacologically hyperleptinemic mice were treated with saline (C) or leptin (L) for 16 days;
(iii) genetically obese mice lacking leptin (ob/ob −/−) and control group (ob/ob +/?). Values presented in grams (g) of body weight and measurements made after weeks
(wk) or days (d) within the specific protocol. Statistical analysis between groups was carried out using simple t-test. Asterisks indicate significant differences (**p < 0.01;
***p < 0.001; ****p < 0.0001).
periodically (Table 3). Ovaries from all groups were collected and
processed for mRNA and protein expression analysis. Real-time
PCR analysis (n = 6–8/group) revealed an increase in Nlrp3 and
Casp1 in 16 L, but a decrease in ob/ob −/− mice (Figure 3B,
p < 0.05). Furthermore, the mRNA of Il-1β was upregulated
in 16 L (Figure 3B, p < 0.05). Finally, the mRNA of Il-18 was
significantly downregulated in the ob/ob −/− group (Figure 3B,
p < 0.05). With regard to protein expression (n = 6–8/group), we
found that the 16 L group presented increased levels of NLRP3
(Figure 3C, p < 0.05), whereas the opposite pattern was observed
in ob/ob −/− mice, compared with control groups (Figure 3C,
p < 0.05). Accordingly, both pro-peptides CASP1 (p45) and
CASP1 (p20) showed increased levels in 16 L (Figures 3D,E;
p = 0.07 and p < 0.05, respectively); nonetheless, no significant
changes were found in the ob/ob model. Importantly, IL-1β
protein levels measured by ELISA (n = 4–5/group) were increased
in 16 L, but decreased in ob/ob −/− (Figure 3F, p < 0.05). In
this experiment, we revealed the functional link between leptin
signaling and NLRP3 inflammasome component regulation in
the ovary, with leptin treatment inducing the activation of NLRP3
and CASP1 with subsequent secretion of IL-1β. Furthermore,
we confirmed the downregulation of NLRP3 expression in the
ovaries of ob/ob−/−.
Leptin Promotes Changes of NOD-Like
Receptor Protein 3 Inflammasome
Components Gene Expression in
Cumulus Cells During Early Onset of
Obesity
In this experiment, we examined whether the association between
leptin signaling and NLRP3 inflammasome activation previously
observed in whole ovaries holds true at the cellular level.
We, therefore, analyzed particularly the somatic companions of
the female gamete, the CCs. We started reanalyzing the RNA
sequencing (RNA-seq) datasets from CCs from 4- and 16-week
DIO and pharmacological hyperleptinemic model (Figure 4A;
Wołodko et al., 2020). We confirmed the expression levels of
leptin and NLRP3 pathway components for 16 L and 4-week
HFD, and despite no changes in Nlrp3 in CCs after 4-week
HFD, the gene was upregulated in 16 L (Figure 4B). The
low coverage of the samples (an average of 5.5 million reads)
and the weak expression level of Nlrp3 in CCs may account
for the lack of changes in 4-week HFD. Nonetheless, the
consistent upregulation of various components of the NLRP3
inflammasome, like Nlrp3, Il-18, Casp1, Il-1β, and Asc in 16 L is
suggestive of the stimulatory effects of leptin on the expression
level and activation of NLRP3 inflammasome genes also in CCs
(Figure 4B). As previously shown, the DESeq analysis of 4-week
DIO protocol revealed 997 differentially expressed genes (DEGs)
in 4-week HFD, whereas for pharmacological hyperleptinemic
model, a total of 2,026 DEGs were found in 16 L (Wołodko
et al., 2020), in comparison with their control groups (p < 0.05;
Wołodko et al., 2020). In the present analysis, we overlapped the
DEGs from 4-week HFD and 16 L and identified seven genes
either up- or downregulated in both conditions (Figure 4C).
Subsequently, we integrated the 14 DEGs with the main
components of NLRP3 and leptin signaling pathways (Wołodko
et al., 2020), based on the correlation between their expression
levels (p > 0.90), and obtaining five clusters (Figure 4D). Of note,
one of the clusters revealed the gene interaction between Casp1,
phosphatase and tensin homolog (Pten) and signal transducer
and activator of transcription 5a (Stat5a), while others showed
a link between Socs3 and Il-1β, known as an important axis
involved in the mediation of immune response (Chaves de Souza
et al., 2013). Importantly, other genes were highlighted in the
network, as solute carrier family 22 member 15 (Slc22a15), a cell
membrane transporter and metabolic gene (Nigam, 2018), or
stress-associated endoplasmic reticulum protein 1 (Serp1) involved
in protein unfolding and stress response (Yamaguchi et al., 1999).
Indeed, metabolic performance in the preovulatory follicle is
tightly regulated and involves the crosstalk between GC and
oocyte (Figure 4D; Wołodko et al., 2021). The gene ontology
analysis for the presented network revealed three main events:
negative regulation of glucose transport, positive regulation of
cytokine biosynthesis, and response to ATP (Figure 4E, p < 0.05).
Finally, we plotted a subset of genes known to directly activate
the NLRP3 inflammasome signaling pathway (Weber et al.,
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FIGURE 3 | Leptin signaling in the ovary drive changes in NLRP3 during obesity. (A) Experimental design: (i) pharmacological hyperleptinemic model, mice were
either injected with saline or 100 µg of leptin (L) for 16 days; (ii) genetic obesity model, mice lacking leptin (ob/ob −/−) or control group (ob/ob +/?). (B) Heatmap
illustrating fold of change in expression of mRNA of genes Nlrp3, Casp1, Il-1β, Il-18, apoptosis-associated speck-like protein-containing A CARD (Asc), Il-10, and
tumor necrosis factor alpha (Tnf ) in hyperleptinemia and ob/ob models determined by real-time PCR. The scale matches colors to log 2 fold change (log2 FC)
values. Abundance of (C) NLRP3, (D) pro CASP1 p45, (E) CASP1 p20 measured by Western blotting, and (F) IL-1β quantified by ELISA, in the mouse ovarian
extracts. Level mRNA normalized with ribosomal protein L37 (Rpl37) value and protein expression with β-actin or glyceraldehyde 3-phosphate dehydrogenase
(GAPDH). Bars represent mean ± SEM. Statistical analysis between groups was carried out using the Mann–Whitney test. Number of samples: n = 6–8 for real-time
PCR analysis, n = 6–8 for immunoblots and n = 4–5 for ELISA. Asterisks indicate significant differences (*p < 0.05; +p = 0.07). AU, arbitrary units.
2020), particularly regarding the regulation of glutathione, major
mediator of NLRP3 signaling (Hughes et al., 2019), as well as
other genes involved in the pathway regulation (Zhou et al., 2010;
Barlan et al., 2011; Iyer et al., 2013; Mitoma et al., 2013; Wang
et al., 2014; Kim et al., 2015; He et al., 2016b; Jo et al., 2016;
Li et al., 2016; Wolf et al., 2016; Guglielmo et al., 2017; Hughes
and O’Neill, 2018; Palazón-Riquelme et al., 2018; Shuvarikov
et al., 2018; Billon et al., 2019; Hughes et al., 2019; Martine
et al., 2019; Zhang et al., 2021). We confirmed a similar behavior
between 16 L and 4-week HFD for those genes, in opposition
to 16-week HFD (Figure 4F). Thus, systemic administration of
leptin-activated genes from the NLRP3 inflammasome pathway
Frontiers in Cell and Developmental Biology | www.frontiersin.org 9 November 2021 | Volume 9 | Article 738731
fcell-09-738731 October 28, 2021 Time: 16:28 # 10
Adamowski et al. Ovarian Leptin Regulates NLRP3-Inflammasome in Obesity
FIGURE 4 | Cumulus cells transcriptome analysis from DIO and pharmacologically hyperleptinemic mice. (A) Experimental design: RNA-Seq analysis of differentially
expressed genes in cumulus cells collected from mice: i) with DIO fed chow diet (CD) or high-fat diet (HFD) for 4 or 16 week (ii) with pharmacologically
hyperleptinemic (LEPT) injected with saline (C) or 100 µg of leptin (L) for 16 days (16 L). (B) Heatmap illustrating expression of genes from leptin signaling pathway
and NLRP3 inflammasome in 16 L and 4- week HFD normalized by control group fed CD or injected with saline, respectively. Downregulated genes in blue,
upregulated genes in orange. The scale on the right matches colors to log 2 fold change (log2 FC) values. (C) Heatmap showing significant changes in major
constitutive genes in both conditions 16 L and 4- week HFD. (D) Five main clusters in the network representing strong interaction between selected genes described
in (B) and genes presented in (C). (E) Pie chart that displays the main three gene ontology terms that were significantly enriched in cumulus cells in both conditions
16 L and 4- week HFD. Gene ontology analysis performed with Gene Ontology Enrichment Analysis and Visualization Tool. (F) Heatmaps showing conserved genes
involved in NLRP3 inflammasome activation, glutathione metabolism, and other regulations. log2 FC of reads per million (RPM). Created with BioRender.com.
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in CCs, corroborating the functional link between leptin signaling
and NLRP3 inflammasome activation in CCs of DIO mice.
Activation of NOD-Like Receptor Protein
3-Induced Inflammasome in the Liver of
Diet-Induced Obesity Mice
In the last experiment, we compared the temporal activation
of NRLP3 inflammasome between the ovary and another
metabolic organ as the liver, during obesity progression. Thus,
we analyzed the expression profile of NLRP3 inflammasome
genes in the liver of DIO mice. Furthermore, we tested once
more the functional link between leptin signaling and activation
of NLRP3 inflammasome in the liver, using pharmacological
hyperleptinemic and ob/ob mouse models. Liver samples
were collected from DIO, leptin treated, and ob/ob female
mice, for mRNA transcription and protein expression analysis
(Figure 5A). Real-time PCR analysis (n = 6–9/group) showed
no significant changes in expression of all inflammasome
components, except for the increase in Nlrp3 and Il-1β mRNA
in 16-week HFD, but downregulation of Nlrp3 in ob/ob−/−
(Figure 5B, p < 0.05). Furthermore, protein analysis determined
by Western blotting (n = 4–8/group) showed an increase in
protein levels of NLRP3, CASP1 (p20), and IL-18 (p18) after 16-
week HFD treatment, compared with control (Figures 5C,E,G,
p < 0.05, p = 0.07, p = 0.08). Regarding the pro-peptide of CASP1
(p45), its protein was upregulated in 16 L, but downregulated
in ob/ob−/−, compared with controls (Figure 5D, p < 0.05
and p < 0.01, respectively). Finally, CASP1 (p20) and IL-18
(p18) proteins were decreased in ob/ob−/− (Figures 5E,G,
p < 0.05 and p = 0.08, respectively). No significant changes
were observed for pro IL-18 (p24) (Figure 5F). The present
results of our analysis in the liver indicate a site-dependent
NLRP3 inflammasome regulation throughout obesity, since
overexpression of NLRP3, CASP1 (p20), and IL-18 (p18) took
place only at 16 week of DIO. Thus, we observed drastic
differences in NLRP3 inflammasome profile between liver
and ovary (Figure 5H), which showed the upregulation of
NLRP inflammasome components after 4-week DIO (Figure 2).
Another important observation was the downregulation of
NLRP3 and CASP1 (p20) in livers from ob/ob −/− mice,
suggesting that leptin directly modulates NLRP3 inflammasome
activation at hepatic level. Hence, we confirmed the latency of
NLRP3 inflammasome activation in the liver of DIO female mice,
which showed signs of upregulation only after 16- week HFD
treatment. Furthermore, we have confirmed the functional link
between leptin and NLRP3 inflammasome activation in the liver.
DISCUSSION
The present study gives the first characterization of NLRP3-
induced inflammasome activation in the ovaries of DIO mice.
Maternal obesity has been largely associated with increased
ovarian inflammation (Robker et al., 2011; Nteeba et al., 2013,
2014; Ruebel et al., 2017; Snider and Wood, 2019). Therefore,
a better knowledge of its pathogenesis will contribute to our
understanding of the mechanisms underpinning ovarian failure
and infertility during obesity. We first studied the effects of
cyclicity on NLRP3 inflammasome activation in the ovaries of
lean mice, confirming the upregulation of NLRP3 inflammasome
components during D. Subsequently, we characterized the
expression profile of NLRP3 inflammasome components in
the ovary throughout obesity progression. Indeed, the rapid
upregulation of NLRP3 protein in early obesity (after 4- week
HFD treatment) was followed by a consistent downregulation of
NLRP3, IL-18, and CASP1 in late obesity (after 16- week HFD).
Importantly, using either a pharmacological hyperleptinemic and
a genetic obese ob/ob mice, we evidenced the functional link
between levels of leptin signaling and NLRP3 activation in whole
ovaries. Furthermore, in CCs collected after superovulation, we
confirmed also the major role of leptin on the upregulation
of Nlrp3, Casp1, Asc, Il-18, and Il-1β transcription. Finally,
after analyzing the NLRP3 inflammasome expression pattern in
the liver, we observed NLRP3, CASP1, and IL-18 upregulation
exclusively after 16- week HFD treatment, showing a delayed
activation of NLRP3 inflammasome activation with regard to the
ovary. Hence, these results suggest a greater vulnerability of the
ovaries, in general, and the gamete, in particular, to the energetic
surplus that females face under obesogenic conditions.
A recent study by Zhang and colleagues showed for the
first time the expression of NLRP3 protein in various cellular
components of mouse ovaries, like GC, TC, and oocytes
(Zhang et al., 2019). We presently observed not only a
similar pattern of cellular expression for NLRP3 but also the
upregulation of NLRP3 inflammasome components during D.
These findings corroborate previous results from Zhang and
colleagues suggesting the involvement of NLRP3 in inflammatory
events during ovulation in mice (Zhang et al., 2019). Moreover,
NLRP3 was recently characterized as an important mediator
of ovarian pathology during aging (Navarro-Pando et al.,
2021). Finally, the involvement of NLRP3 inflammasome in
ovarian inflammatory response in obese mothers is supported
by previous reports showing NLRP3 inflammasome activation
in proinflammatory conditions like PCOS (Wang et al.,
2017; Guo et al., 2020). Thus, NLRP3 inflammasome may
contribute for the regulation of key mechanisms during ovarian
physiology and pathology.
The NLRP3 inflammasome is a critical component of innate
immunity, frequently associated with human disease (He et al.,
2016a). Our results evidencing NLRP3 inflammasome activation
in the ovaries in early obesity (after 4- week HFD) are in line with
previous reports showing the accumulation of proinflammatory
mediators in the ovary of mice after short-term (6- week HFD)
DIO (Shen et al., 2021). Indeed, we presently observed the
upregulation of IL-18 protein, as well as the mRNA of Tnf
(data not shown), after 4- week HFD supporting the early
establishment of inflammatory response in the ovaries of DIO
mice. Nonetheless, the regulation of ovarian inflammation in late
obesity (16- week HFD) seems to be independent from NLRP3
inflammasome activation, as IL-18 and CASP1 mature proteins
were significantly downregulated. Undeniably, increased levels
of IL-1β in the ovaries of 16- week HFD mice confirmed the
proinflammatory state existent in the ovaries. Of note, our results
were confirmed by another study showing the upregulation of
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FIGURE 5 | NLRP3 activity in the liver of DIO, hyperleptinemic, and genetically obese mice. (A) Experimental design: (i) DIO mice were fed CD or HFD for 4 or
16 week; (ii) pharmacologically hyperleptinemic mice were treated with saline (C) or 100 µg of leptin (L) for 16 days; (iii) genetically obese mice lacking leptin
(ob/ob−/−) and control group (ob/ob +/?). (B) Heatmap illustrating fold change in expression of mRNA of genes Nlrp3, Casp1, Il-1β, and Il-18, Asc, Il-10, and Tnf in
DIO, hyperleptinemia, and ob/ob models in comparison with respective controls, determined by real-time PCR. The scale on the right matches colors to log2 fold
change (log2 FC) values. Data normalized to mRNA expression of ribosomal protein L37 (Rpl37). Abundance of (C) NLRP3, (D) pro CASP1 p45, (E) CASP1 p20, (F)
pro IL-18 p24, and (G) IL-18 p18 in mouse liver of DIO, hyperleptinemic, and ob/ob mice measured in Western blotting analysis. Protein normalized with β-actin or
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) level. Bars represent mean ± SEM. Statistical analysis between groups was carried out using Mann–Whitney
test. Number of samples: n = 6–9 for real-time PCR analysis and n = 4–8 for immunoblots. Asterisks indicate significant differences (*p < 0.05; **p < 0.01;
+p = 0.07; +p = 0.08—all values indicated). AU, arbitrary units. (H) Diagram summarizing the profile of NLRP3 inflammasome activation in ovaries and liver of DIO
mice. Figure 5H created with BioRender.com.
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the proinflammatory mediators like Il-1β, Il-6, and Tnfα in the
ovaries of mice fed HFD for 24 week (Nteeba et al., 2013).
Hence, our results suggest the existence of alternative pathways
to NLRP3 inflammasome mediating IL-1β upregulation in mouse
ovaries at 16- week HFD (Schmidt and Lenz, 2012; Zhu
and Kanneganti, 2017; Donado et al., 2020; Jain et al., 2020;
Pyrillou et al., 2020).
We have recently characterized the temporal pattern of
expression of proinflammatory genes in CCs from DIO mice
(Wołodko et al., 2020). In early obesity, inflammatory cues
in CCs were mediated by the upregulation of genes involved
in cellular response to stress as DEAD-box helicase 5 (Ddx5),
hypoxia inducible factor 1 subunit alpha (Hif1a), and ADAM
metallopeptidase domain 9 (Adam9). Indeed, mediators of stress
response like reactive oxygen species are known to prime the
NLRP3 inflammasome (Gurung et al., 2014). Subsequently, in
late obesity, we observed the overexpression of genes involved
in anatomical structural morphogenesis, such as C–C motif
chemokine ligand 7 (Ccl7), an important chemoattractant of
leukocytes (Menten et al., 1999). Furthermore, Ccl7 is also known
to interact with matrix metalloproteinases (MMPs) (Liu et al.,
2018) or complement C3a receptor 1 (C3ar1), a component
of the complement known to mediate neutrophil mobilization
(Brennan et al., 2019) and lately described as a marker of
PCOS progression (He et al., 2020). Therefore, these data
suggest important temporal changes in the regulation of the
inflammatory response in the ovary of mice throughout obesity
progression. Indeed, NLRP3 inflammasome seems to play a
critical role mostly in the initiation of inflammation in the
ovaries in early obesity. Conversely, in late obesity, immune-
mediated response in the ovary mainly comprises the infiltration
of immune cells and mediation of structural reorganization,
independent from the activation of NLRP3 inflammasome.
Our study also sheds light on the important crosstalk between
leptin signaling and inflammasome NLRP3 activation in the
ovary of DIO mice. As reviewed by Wani et al. (2021), numerous
factors were shown to activate NLRP3 inflammasome during
obesity, such as cellular metabolites, carbohydrates, or lipids.
Nonetheless, leptin, a conserved proinflammatory cytokine
(Iikuni et al., 2008; La Cava, 2017), was recently shown to
upregulate NLRP3 components in vitro (Fu et al., 2017). Thus,
in order to test the hypothesis whether repression of NLRP3
inflammasome activation in ovaries of 16- week HFD mice
was associated with the local establishment of leptin resistance
(Wołodko et al., 2020), we studied NLRP3 inflammasome
activation in the ovaries of pharmacological hyperleptinemic and
ob/ob mice. Strikingly, we observed a consistent upregulation of
NLRP3 inflammasome components and accumulation of IL-1β
protein in ovaries of leptin-treated mice. Conversely, in ob/ob
−/− mice, NLRP3 and IL-1β proteins were downregulated.
Furthermore, reduced levels of NLRP3 were also observed in
ob/ob −/− mouse peritoneal macrophages treated with LPS
and nigericin in comparison with wild-type mice (Yang et al.,
2021). This certainly underlines the preponderant role of leptin
on NLRP3 inflammasome regulation. Therefore, our results
invite us to suggest an important link between levels of leptin
signaling in the ovary of DIO mice and activation of NLRP3
inflammasome. In early obesity (4- week HFD), leptin actively
signals through receptor b (ObRb) in the ovary (Wołodko et al.,
2020), determining the overexpression of NLRP3 inflammasome
components. Nonetheless, in late obesity (16- week HFD),
and after the establishment of leptin resistance in the organ
(Wołodko et al., 2020), the expression of NLRP3 inflammasome
components is repressed.
Next, we reanalyzed our datasets on global gene expression in
CCs collected from DIO and pharmacological hyperleptinemic
mice in order to test the association between leptin signaling and
activation of NLRP3 inflammasome in the somatic companions
of the oocyte. Importantly, CCs are known as faithful indicators
of intrafollicular environment (Wołodko et al., 2021), and their
transcriptome has been previously used to predict oocyte and
embryo quality (Uyar et al., 2013). Despite no changes in
4- week HFD, we confirmed the overexpression of NLRP3
inflammasome genes in CCs from 16 L. Consequently, we
interrogated whether DEGs overlapping both 16 L and 4- week
HFD treatment could interact with NLRP3 inflammasome genes.
Indeed, gene ontology for associated genes revealed key terms
for oocyte maturation, such as regulation of glucose transport,
response to ATP, and regulation of cytokine biosynthesis.
Metabolic regulation in preovulatory follicles appears to control
major steps for maturation of female gamete, such as meiosis
resumption, chromatin condensation, and cytoplasm maturation
(Wołodko et al., 2021). For instance, glucose metabolism,
which takes place mostly in CCs (Sanfins et al., 2018) was
shown to be a key for oocyte competence (Wilding et al.,
2009). Furthermore, reduced ATP content in oocytes was
linked to failure in fertilization, arrested division, and abnormal
embryonic development (Zhao and Li, 2012). Furthermore,
NLRP3 inflammasome was previously reported to be involved
in ovulation (Zhang et al., 2019). Given both direct and indirect
roles of leptin in ovulation (Wołodko et al., 2021), the failure
in leptin signaling and NLRP3 inflammasome activation in
late obesity could account for increased anovulatory rates in
obese mothers (Wu et al., 2010; Hou et al., 2016). Finally, the
absence of changes in 4- week HFD in NLRP3 inflammasome
genes can be ascribed to the low levels of coverage of our
reduced-cell libraries and also the low levels of Nlrp3 mRNA
expression. Indeed, the present RNA-seq protocol used as little
as 50 cells per mouse, which limits the analysis of weakly
expressed genes. Collectively, our results indicate that leptin and
NLRP3 inflammasome crosstalk in CCs of DIO mice can interfere
with key steps for oocyte maturation, ovulation, and ultimately
embryo development.
In the last experiment, we confirmed that the liver, in
sharp contrast to the ovary, activated NLRP3 inflammasome
later in time during DIO (after 16- week HFD treatment).
Temporal differences in the regulation of inflammatory response
(Figure 5H) certainly rely on the contrasting exposition to
exogenous pathogens both organs face. The liver is constantly
exposed to proinflammatory mediators from dietary and
commensal bacterial products (Robinson et al., 2016). Thus, the
hepatic immune system is constantly in contact with altered
metabolic activity and regular exposition to microbial products,
which results in persistent and tightly regulated inflammatory
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response (Robinson et al., 2016). On the contrary, the ovary is
not only a highly immunogenic organ constantly secreting large
amounts of cytokines and immune mediators (Piccinni et al.,
2021) but also more prone to rapidly mount a proinflammatory
response during obesity. Indeed, the inability of the ovary to
control inflammation, and the exacerbated activation of cytokine
production, certainly ascribes for the great vulnerability of the
female gamete to maternal obesity even at earlier stages of
disease progression. Thus, our results expose the increased
vulnerability of the ovaries to maternal obesity, characterized by
the development of an early inflammatory response that rapidly
affects the gamete and impairs fertilization.
In summary, our work evidences the major role of leptin
signaling on NLRP3 inflammasome activation in the ovary of
mice during early obesity. Noteworthy, failure in ovarian leptin
signaling in late obesity was associated with the repression in
NLRP3 activity, but with maintenance of inflammation and
levels of IL-1β. Moreover, NLRP3 inflammasome activation in
the ovaries after early obesity contrasted with its activation
exclusively during late obesity in the liver. Hence, the present
findings suggest a greater vulnerability of the ovary, in general,
and the gamete, in particular, to the energetic surplus during
maternal obesity.
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